These success, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the principle of focusing on ACKR3 as a novel approach to modulate the opioid method, which could open up new therapeutic avenues for opioid-related disorders. A completely new research https://philr468oia4.newsbloger.com/profile